Nancy Lee, MD - ASTRO
Nancy Lee, MD - ASTRO
Nancy Lee, MD - ASTRO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Induction Chemotherapy Followed<br />
By Concurrent Chemoradiotherapy<br />
• Median Follow-up: 28 months<br />
• Response to induction chemotherapy:<br />
PPartial: i l 52%<br />
Complete: 35%<br />
• 2-year local control: 94%<br />
• 22-year year distant control: 93%<br />
• 2-year overall survival: 77%<br />
• 3-year 3 year progression progression-free free survival: 80%<br />
• Five patients PEG dependent at 1 year